We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Wearable Rapid Gas Analyzer Could Detect Illness Immediately

By LabMedica International staff writers
Posted on 08 Aug 2022
Print article
Image: Associate Professor Yuze “Alice” Sun is creating a wearable device for rapid gas analysis (Photo courtesy of The University of Texas at Arlington)
Image: Associate Professor Yuze “Alice” Sun is creating a wearable device for rapid gas analysis (Photo courtesy of The University of Texas at Arlington)

Advancements in micro-gas chromatography in the past 20 years have demonstrated great potential for the development of powerful portable gas analysis devices. But it remains a challenge to achieve efficient separation and rapid detection for effective gas analysis in a highly integrated and cost-effective platform, as well as in a mobile device. Now, researchers are creating a portable, wearable device for rapid gas analysis that could detect illness immediately.

The device being created by electrical engineering researchers at The University of Texas at Arlington (Arlington, TX, USA) will play an important role in health care, among other sectors. The project will create technology to transform a powerful gas analysis instrument traditionally used in research labs into portable and wearable devices that are easily accepted and accessible by the public. The project has received a USD 550,000 National Science Foundation (NSF) grant from the Partnerships for Innovation–Research Partnerships program, which aims to take devices developed in the laboratory to the marketplace more quickly.

The vast applications could propel the device to the marketplace more quickly. In health care, the device could analyze a person’s breath samples to find chemical markers that are specifically linked to infections, cancers and other health conditions. In turn, that could lead to a convenient and rapid health screening and monitoring tool to be used at home.

“The key to the project is system-level integration, including creating new micro-gas chromatography architecture and using photonic integrated circuits to achieve rapid and comprehensive volatile organic compounds gas analysis,” said Yuze “Alice” Sun, an associate professor in the Department of Electrical Engineering, who is the principal investigator on the project.

“Not only does the project have the potential of improving our lives, but it could take up so much less space than current chromatography analysis machines,” said Diane Huffaker, chair and professor of electrical engineering. “This could save an enormous amount of testing time, too.”

Related Links:
The University of Texas at Arlington 

New
Gold Supplier
Vaginosis Test
VAGINAL PANEL REALTIME PCR KIT
New
TSI Stimulating Assay
Thyretain TSI Stimulating Reporter BioAssay
New
HPLC System
Jasper HPLC System
New
Whole Blood Control
ESR-Chex Plus

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Special blood test could determine if patient has early stage breast cancer and if the cancer is unlikely to return (Photo courtesy of USC)

Simple Blood Draw Could Revolutionize Early Breast Cancer Detection

Breast cancer is the most prevalent form of cancer in the world, affecting one in eight women over their lifetime. Since 1976 when the American Cancer Society endorsed mammography X-rays, the technique... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.